The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity
遗传变异、年龄、饮食、性别和线粒体拷贝数对阿尔茨海默病、衰老表型和寿命的相互作用
基本信息
- 批准号:10367582
- 负责人:
- 金额:$ 49.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAge-MonthsAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease riskBehavioralBioinformaticsBiological AssayBiological MarkersBiological ModelsBiologyBloodCandidate Disease GeneCell physiologyCognitionCognitiveCollectionComplexDNADNA copy numberDataData SetDatabasesDietDiseaseEnvironmentEtiologyFamilyFatty acid glycerol estersFutureGenerationsGenesGeneticGenetic EngineeringGenetic VariationGenomeHealthHigh Fat DietHippocampus (Brain)HumanHuman GenomeImpaired cognitionInbreedingIndividualInternetInterventionKidneyLearningLinkLiverLiver MitochondriaLongevityMeasuresMediatingMemoryMetabolicMitochondriaMitochondrial DNAModelingMolecularMotorMouse StrainsMusMuscleOutcomeOutcome MeasureOutcome StudyPathogenicityPerformancePeripheralPhenotypePopulationProcessProteomeProxyQTL GenesQuantitative Trait LociReactive Oxygen SpeciesRecombinantsReproducibilityResearch ProposalsSamplingServicesSeverity of illnessSex DifferencesSkinSystemTestingTissuesTransgenesTransgenic OrganismsTranslatingVariantWhole OrganismWorkage effectage relatedbiobankcell typeclinical applicationcognitive performancecohortdata integrationendophenotypefamilial Alzheimer diseasefunctional declinegene environment interactiongenetic analysisgenetic resourcegenetic variantgenome wide association studygenome-widegenomic locushealthy agingimprovedmetabolomemouse modelnovelnovel therapeutic interventionphenomeprecision medicinesexsuccesstraittranscriptome sequencingweb site
项目摘要
As the average age of the population increases, understanding the biology of longevity and diseases of aging
is increasingly important. The key role of mitochondria in Alzheimer’s disease (AD) and pathogenic aging has
been established in studies across species and mechanistically validated using genetically engineered
models. Mitochondrial DNA copy number (mtDNAcn) changes with age and diet, in various tissues, and
across species. Higher mtDNAcn is associated with better health outcomes in aging and with increased
longevity, while decreased mtDNAcn is linked to disorders of aging including AD. However, we do not
understand the mechanistic interaction between genetic variants, mtDNAcn, diet, sex, aging and AD. Here
we propose to identify gene-by-environment interactions (GxE) that link mtDNAcn to AD- and aging- relevant
phenotypes already collected in the recombinant inbred BXD and transgenic AD-BXD mouse lines, including
longevity, memory, learning, motor, and neuroanatomical phenotypes. In Aims 1 and 2, we will test GxE, and
identify loci underlying these interactions in three “peripheral” (skin, blood, muscle) and three “central” (liver,
kidney, hippocampus) tissues. We will use previously gathered tissue from 45 BXD strains between 6- and
24-months old that had been fed either standard chow or high-fat diet, and quantify mtDNAcn. In Aim 3, we
will identify relationships between mtDNAcn, age, sex and the familial AD transgenes (5XFAD), using tissue
already collected from the AD-BXD. As part of Aims 2 and 3, we will re-produce a subset of the above strains
and carry out analysis of mitochondrial function and reactive oxygen species generation to determine the link
between mtDNAcn and mitochondrial function across tissues. In Aim 4, we will integrate our generated data
with extensive behavioral data on age-related cognitive and other behavioral and CNS changes generated
from BXD and AD-BXD. This will allow us to define loci, candidate genes, and mechanisms of AD and
longevity and to systematically test for associations with age, sex, diet, and linked changes in mitochondrial
DNAcn or function. Finally, we will integrate previously generated -omics data that we have for BXD and other
genomes (e.g., RNA-seq, meth-seq, metabolomes and proteomes) with data from large human AD and
mtDNAcn GWASs, and other existing -omics data. All results will be shared openly using robust internet
services—Mouse Phenome Database, GeneNetwork, etc. Data and workflows will be FAIR-compliant. Key
deliverables are far more quantitative, unbiased, global, and replicable data on genetic, molecular, and
environmental processes that act with mitochondria to mediate cognitive loss, AD and longevity. We will also
deliver causal molecular and mechanistic models that incorporate realistically high levels of genetic diversity—
6 million DNA variants. This work empowers in-depth, unbiased analyses of age-related functional decline
that translates to human populations. Success will provide a platform in which to test novel interventions in
this genomically- and environmentally- replicable population — so called “experimental precision medicine”.
随着人口的平均年龄增加,了解寿命的生物学和衰老的疾病
越来越重要。线粒体在阿尔茨海默氏病(AD)和致病性衰老中的关键作用具有
在跨物种的研究中建立,并使用基因工程进行机械验证
型号。线粒体DNA拷贝数(mTDNACN)随着年龄和饮食的不同而变化,
跨物种。较高的mtdnaCn与衰老的健康状况更好,并且随着增加而增加
长寿的同时下降了mtdnaCn,与包括AD在内的衰老障碍有关。但是,我们没有
了解遗传变异,MTDNACN,饮食,性别,衰老和AD之间的机械相互作用。这里
我们建议确定将mtdnaCn与AD和衰老相关的基因相互作用(GXE)
已经收集的表型已经收集在重组的近交BXD和转基因AD-BXD小鼠系中,包括
寿命,记忆,学习,运动和神经解剖表型。在目标1和2中,我们将测试GXE,并
在三个“外围”(皮肤,血液,肌肉)和三个“中央”(肝脏,
肾脏,海马组织。我们将在6-和6和6之间的45个BXD菌株中使用以前收集的组织
24个月大的年龄,已被喂食标准食物或高脂饮食,并量化mtdnaCn。在AIM 3中,我们
将使用组织确定MTDNACN,年龄,性别和家庭广告翻译(5xFAD)之间的关系
已经从AD-BXD收集。作为目标2和3的一部分,我们将重新生产上述菌株的子集
并进行线粒体功能和活性氧的产生分析以确定联系
在组织之间的mtdnaCn和线粒体功能之间。在AIM 4中,我们将整合生成的数据
借助与年龄相关的认知和其他行为和中枢神经系统变化产生的广泛行为数据
来自BXD和AD-BXD。这将使我们能够定义局部,候选基因以及AD的机制和
寿命并系统地测试与年龄,性别,饮食和线粒体的连接变化的关联
DNACN或功能。最后,我们将集成以前生成的 - 摩学数据,我们为BXD和其他
基因组(例如RNA-seq,Meth-Seq,代谢组和蛋白质组),并带有来自大型人类AD的数据
mtdnacn gwass和其他现有的 - 摩学数据。所有结果将使用强大的互联网公开共享
服务 - Mouse现象数据库,GenEnetwork等。数据和工作流程将是合理的。钥匙
可交付成果更具定量性,无偏见,全球和可复制的数据,有关遗传,分子和分子
用线粒体起作用的环境过程可以介导认知损失,AD和寿命。我们也会
提供因果分子和机械模型,这些模型结合了现实水平的遗传多样性 -
600万个DNA变体。这项工作使对年龄相关功能下降的深入,无偏分析
这转化为人口。成功将提供一个测试新颖干预措施的平台
这种在基因组和环境上可复制的人群 - 所谓的“实验精确医学”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David George Ashbrook其他文献
David George Ashbrook的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David George Ashbrook', 18)}}的其他基金
The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity
遗传变异、年龄、饮食、性别和线粒体拷贝数对阿尔茨海默病、衰老表型和寿命的相互作用
- 批准号:
10551316 - 财政年份:2022
- 资助金额:
$ 49.14万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 49.14万 - 项目类别:
The impact of auditory access on the development of speech perception
听觉访问对言语感知发展的影响
- 批准号:
10677429 - 财政年份:2023
- 资助金额:
$ 49.14万 - 项目类别:
Mucosal immunity to sapovirus in early childhood
幼儿期对沙波病毒的粘膜免疫
- 批准号:
10677051 - 财政年份:2023
- 资助金额:
$ 49.14万 - 项目类别:
Hypothalamic Sleep-Wake Neuron Defects in Alzheimer’s disease
阿尔茨海默病中的下丘脑睡眠-觉醒神经元缺陷
- 批准号:
10770001 - 财政年份:2023
- 资助金额:
$ 49.14万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 49.14万 - 项目类别: